1.
Karupiah MK, Fong CS, Mustafa N. THE EFFECT OF LUSEOGLIFLOZIN ON CARDIOMETABOLIC MARKERS IN PATIENTS WITH PREDIABETES (IMPAIRED GLUCOSE TOLERANCE): A PILOT STUDY. J ASEAN Fed Endocr Soc [Internet]. 2021Jul.28 [cited 2024May1];36:13. Available from: https://www.asean-endocrinejournal.org/index.php/JAFES/article/view/1369